Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Orthomyxoviridae”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00542776
What this trial is testing

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

Who this might be right for
Inflammatory Bowel Disease (IBD)Immunosuppressed or Non-ImmunosuppressedInfluenza Vaccine+2 more
Boston Children's Hospital 146
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Testing effectiveness (Phase 2)Looking for participantsNCT07779408
What this trial is testing

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Who this might be right for
Healthy VolunteersInfluenza
Sanofi 640
Very early researchStudy completedNCT04901455
What this trial is testing

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
University of North Carolina, Chapel Hill 24
Large-scale testing (Phase 3)Study completedNCT03969212
What this trial is testing

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Who this might be right for
Influenza
Hoffmann-La Roche 4,138
Testing effectiveness (Phase 2)UnknownNCT01006681
What this trial is testing

Vaccination Against Influenza H1N1 in Rheumatic Diseases

Who this might be right for
InfluenzaRheumatic Diseases
Tel-Aviv Sourasky Medical Center 400
Large-scale testing (Phase 3)Study completedNCT05273619
What this trial is testing

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Who this might be right for
Common ColdAcute Respiratory InfectionInfluenza, Human
Valenta Pharm JSC 250
Not applicableUnknownNCT04568044
What this trial is testing

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Who this might be right for
COVID-19Pregnancy RelatedInfluenza, Human
Imperial College London 128
Not applicableStudy completedNCT01156701
What this trial is testing

Prophylactic Efficacy of Relenza Against Influenza A and B

Who this might be right for
Pulmonary Disease, Chronic ObstructiveBronchospasmInfluenza, Human+7 more
GlaxoSmithKline 171,705
Not applicableStudy completedNCT02334514
What this trial is testing

The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection

Who this might be right for
Influenza
Rambam Health Care Campus 215
Testing effectiveness (Phase 2)Study completedNCT05606965
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 172
Not applicableUnknownNCT01096225
What this trial is testing

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Who this might be right for
Human Influenza
Chinese Academy of Sciences 20
Not applicableStudy completedNCT02893878
What this trial is testing

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

Who this might be right for
Influenza, Human
GlaxoSmithKline 19,334
Testing effectiveness (Phase 2)Study completedNCT02427750
What this trial is testing

Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.

Who this might be right for
Human Influenza
Novartis 126
Large-scale testing (Phase 3)Study completedNCT00462215
What this trial is testing

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 550
Not applicableStudy completedNCT04077697
What this trial is testing

Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.

Who this might be right for
Invasive Pulmonary AspergillosisMorality
Centre Hospitalier Universitaire, Amiens 35
Post-approval studies (Phase 4)Study completedNCT00138385
What this trial is testing

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00814385
What this trial is testing

Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04

Who this might be right for
Influenza
University Hospitals, Leicester 606
Not applicableStudy completedNCT00170508
What this trial is testing

Young Adult Influenza Vaccine Immunogenicity Substudy

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Not Yet RecruitingNCT07349017
What this trial is testing

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

Who this might be right for
Influenza
Changchun BCHT Biotechnology Co. 160
Next Page